相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregation
Haley M Geertsma et al.
HUMAN MOLECULAR GENETICS (2022)
Phosphorylation of the aggregate-forming protein alpha-synuclein on serine-129 inhibits its DNA-bending properties
Sydney E. Dent et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Phosphorylation of endogenous α-synuclein induced by extracellular seeds initiates at the pre-synaptic region and spreads to the cell body
Shiori Awa et al.
SCIENTIFIC REPORTS (2022)
The C-terminal tail of α-synuclein protects against aggregate replication but is critical for oligomerization
Azad Farzadfard et al.
COMMUNICATIONS BIOLOGY (2022)
O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate forTau and?-Synuclein Proteinopathies
Bruno Permanne et al.
ACS CHEMICAL NEUROSCIENCE (2022)
Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition
Azad Farzadfard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity
Simona S. Ghanem et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Serine/Threonine Protein Phosphatase 2A Regulates the Transport of Axonal Mitochondria
Keunjung Heo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2022)
Mechanisms of enhanced aggregation and fibril formation of Parkinson's disease-related variants of α-synuclein
Takashi Ohgita et al.
SCIENTIFIC REPORTS (2022)
Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson's Disease and Multiple System Atrophy
Berkiye Sonustun et al.
CELLS (2022)
Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease
Chao-Wen Lin et al.
GEROSCIENCE (2022)
Glycation modulates glutamatergic signaling and exacerbates Parkinson's disease-like phenotypes
Ana Chegao et al.
NPJ PARKINSONS DISEASE (2022)
Rapid macropinocytic transfer of ?-synuclein to lysosomes
Armin Bayati et al.
CELL REPORTS (2022)
Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models
Ying Xue Xie et al.
NATURE COMMUNICATIONS (2022)
Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrils
Omid Tavassoly et al.
FEBS JOURNAL (2021)
Acetylation Rather than H50Q Mutation Impacts the Kinetics of Cu(II) Binding to α-Synuclein
Xiangyu Teng et al.
CHEMPHYSCHEM (2021)
Behavioral Deficits and Brain α-Synuclein and Phosphorylated Serine-129 α-Synuclein in Male and Female Mice Overexpressing Human α-Synuclein
Lilit Gabrielyan et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders
Vasilios C. Constantinides et al.
BRAIN SCIENCES (2021)
Effects of Excess Brain-Derived Human α-Synuclein on Synaptic Vesicle Trafficking
Cristina Roman-Vendrell et al.
FRONTIERS IN NEUROSCIENCE (2021)
The hereditary mutation G51D unlocks a distinct fibril strain transmissible to wild-type α-synuclein
Yunpeng Sun et al.
NATURE COMMUNICATIONS (2021)
Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson's Disease
Songzhe He et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2
Kazunori Sano et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson's disease
Elena Vacchi et al.
NPJ PARKINSONS DISEASE (2021)
α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson's Disease
Kathrine Stokholm et al.
BIOMEDICINES (2021)
Phosphorylated α-synuclein aggregated in Schwann cells exacerbates peripheral neuroinflammation and nerve dysfunction in Parkinson's disease through TLR2/NF-κB pathway
Li Sun et al.
CELL DEATH DISCOVERY (2021)
Cerebrospinal α-Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort
Nour K. Majbour et al.
MOVEMENT DISORDERS (2021)
In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129
Leah J. Weston et al.
NEUROBIOLOGY OF DISEASE (2021)
DNA Double-Strand Breaks: A Double-Edged Sword for Trypanosomatids
Marcelo Santos da Silva
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit
Alessandro Tozzi et al.
BRAIN (2021)
Ncx3-Induced Mitochondrial Dysfunction in Midbrain Leads to Neuroinflammation in Striatum of A53t-α-Synuclein Transgenic Old Mice
Rossana Di Martino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders
Isabel Schulz et al.
MOVEMENT DISORDERS (2021)
The N terminus of α-synuclein dictates fibril formation
Ryan P. McGlinchey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Histone post-translational modifications as potential therapeutic targets for pain management
Jose Torres-Perez et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion
Qilin Tang et al.
CELL DEATH & DISEASE (2021)
Altered conformation of a-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson's disease
Luis Fonseca-Ornelas et al.
CELL REPORTS (2021)
α-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes
Aysegul Dilsizoglu Senol et al.
PLOS BIOLOGY (2021)
Low-Expressing Synucleinopathy Mouse Models Based on Oligomer-Forming Mutations and C-Terminal Truncation of α-Synuclein
Ana Martinez Hernandez et al.
FRONTIERS IN NEUROSCIENCE (2021)
RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies
Ilaria Poggiolini et al.
BIOMOLECULES (2021)
A SUMO1-Derived Peptide Targeting SUMO-Interacting Motif Inhibits α-Synuclein Aggregation
Zhaohui Liang et al.
CELL CHEMICAL BIOLOGY (2021)
Parkinson disease
R. Balestrino et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls
Linda P. Oosterveld et al.
MOVEMENT DISORDERS (2020)
Molecular mechanisms in SUMO conjugation
Nathalia Varejao et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Role of Post-translational Modifications in Alzheimer's Disease
Madhu Ramesh et al.
CHEMBIOCHEM (2020)
The involvement of post-translational modifications in cardiovascular pathologies: Focus on SUMOylation, neddylation, succinylation, and prenylation
Jinning Gao et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Ubiquitination Can Change the Structure of the α-Synuclein Amyloid Fiber in a Site Selective Fashion
Stuart P. Moon et al.
JOURNAL OF ORGANIC CHEMISTRY (2020)
Alpha-synuclein fragments trigger distinct aggregation pathways
Tasnim Chakroun et al.
CELL DEATH & DISEASE (2020)
The N-terminal Acetylation of α-Synuclein Changes the Affinity for Lipid Membranes but not the Structural Properties of the Bound State
Matteo Runfola et al.
SCIENTIFIC REPORTS (2020)
Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
Chun-Wei Chang et al.
FRONTIERS IN NEUROLOGY (2020)
Parkinson's disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure
Kun Zhao et al.
NATURE COMMUNICATIONS (2020)
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers
Nour K. Majbour et al.
TRANSLATIONAL NEURODEGENERATION (2020)
N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity
Rodrigo Vinueza-Gavilanes et al.
NEUROBIOLOGY OF DISEASE (2020)
Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy
Zachary A. Sorrentino et al.
NEUROSCIENCE LETTERS (2020)
Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review
Larissa-Nele Schaffert et al.
BRAIN SCIENCES (2020)
Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein
Yuan Guan et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity
Amberley D. Stephens et al.
NATURE COMMUNICATIONS (2020)
SUMOylation in alpha-Synuclein Homeostasis and Pathology
Mor Savyon et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Phosphorylated Alpha-Synuclein Within Cutaneous Autonomic Nerves of Patients With Parkinson's Disease: The Implications of Sample Thickness on Results
Ningshan Wang et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2020)
O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effect
Kai Wu et al.
PHYSICAL BIOLOGY (2020)
Deciphering protein post-translational modifications using chemical biology tools
Anne C. Conibear
NATURE REVIEWS CHEMISTRY (2020)
The SUMO Conjugase Ubc9 Protects Dopaminergic Cells from Cytotoxicity and Enhances the Stability of α-Synuclein in Parkinson's Disease Models
Dinesh Kumar Verma et al.
ENEURO (2020)
Alpha-Synuclein Accumulation and Its Phosphorylation in the Enteric Nervous System of Patients Without Neurodegeneration: An Explorative Study
Lu-Lu Bu et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
New Insights Into Drug Discovery Targeting Tau Protein
Yoshiyuki Soeda et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20
Briana R. De Miranda et al.
NPJ PARKINSONS DISEASE (2020)
O-GlcNAcylation regulates dopamine neuron function, survival and degeneration in Parkinson disease
Byeong Eun Lee et al.
BRAIN (2020)
Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein
Raquel Pinho et al.
HUMAN MOLECULAR GENETICS (2019)
Cerebrospinal Fluid Total and Phosphorylated -Synuclein in Patients with Creutzfeldt-Jakob Disease and Synucleinopathy
Matthias Schmitz et al.
MOLECULAR NEUROBIOLOGY (2019)
Probing Membrane Association of α-Synuclein Domains with VDAC Nanopore Reveals Unexpected Binding Pattern
Daniel Jacobs et al.
SCIENTIFIC REPORTS (2019)
Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution
Xi Li et al.
SCIENTIFIC REPORTS (2019)
Alpha-Synuclein Continues to Enhance SNARE-Dependent Vesicle Docking at Exorbitant Concentrations
Brenden J. D. Hawk et al.
FRONTIERS IN NEUROSCIENCE (2019)
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration
Valentina Durante et al.
BRAIN (2019)
Glycation of α-synuclein amplifies the binding with glyceraldehyde-3-phosphate dehydrogenase
Pavel Semenyuk et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Post-translational regulation of ubiquitin signaling
Lei Song et al.
JOURNAL OF CELL BIOLOGY (2019)
Effects of alpha-synuclein post-translational modifications on metal binding
Nazareno Gonzalez et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade
Connie Marras et al.
MOVEMENT DISORDERS (2019)
The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson's Diseases
Jiaming Zhang et al.
FRONTIERS IN NEUROSCIENCE (2019)
Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease
Chen Tian et al.
TRANSLATIONAL NEURODEGENERATION (2019)
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease
Brit Mollenhauer et al.
MOVEMENT DISORDERS (2019)
A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathology
Juan A. Gerez et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders
Allison J. Schaser et al.
SCIENTIFIC REPORTS (2019)
Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein
Katsuya Araki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
Cristina Cariulo et al.
FRONTIERS IN NEUROSCIENCE (2019)
Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons
Goutham K. Ganjam et al.
CELL DEATH & DISEASE (2019)
Modification by glyceraldehyde-3-phosphate prevents amyloid transformation of alpha-synuclein
Kseniya Barinova et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)
Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease
Najiba Mammadova et al.
NEUROBIOLOGY OF DISEASE (2019)
α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease
Paul M. Levine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Ginkgolic acid promotes autophagy-dependent clearance of intracellular alpha-synuclein aggregates
Shamini Vijayakumaran et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
The many substrates and functions of NEDD4-1
Xi Huang et al.
CELL DEATH & DISEASE (2019)
Cell Biology and Pathophysiology of α-Synuclein
Jacqueline Burre et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation
Cristine Betzer et al.
EMBO REPORTS (2018)
Refolding of helical soluble α-synuclein through transient interaction with lipid interfaces
Matteo Rovere et al.
FEBS LETTERS (2018)
Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease
Fudong Yan et al.
MEDICINE (2018)
Phosphorylated alpha-Synuclein in the Retina Is a Biomarker of Parkinson's Disease Pathology Severity
Isabel Ortuno-Lizaran et al.
MOVEMENT DISORDERS (2018)
Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death
Lasse Reimer et al.
NEUROBIOLOGY OF DISEASE (2018)
α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies
Iryna Prots et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease
Marthe H. R. Ludtmann et al.
NATURE COMMUNICATIONS (2018)
The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality
Jyotiska Chaudhuri et al.
CELL METABOLISM (2018)
Alpha-Synuclein Modulates the Physical Properties of DNA
Kai Jiang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Levodopa in Parkinson's Disease: Current Status and Future Developments
Nicola Tambasco et al.
CURRENT NEUROPHARMACOLOGY (2018)
Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum
Thaiany Quevedo Melo et al.
NEUROCHEMICAL RESEARCH (2018)
Endoplasmic reticulum stress and apoptosis induced by manganese trigger alpha-synuclein accumulation
Hyonok Yoon et al.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH (2018)
The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy
Fatima Ardito et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease
Velmarini Vasquez et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Protein O-GlcNAcylation: emerging mechanisms and functions
Xiaoyong Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Non-motor features of Parkinson disease
Anthony H. V. Schapira et al.
NATURE REVIEWS NEUROSCIENCE (2017)
SUMOylation and ubiquitination reciprocally regulate α-synuclein degradation and pathological aggregation
Ruth Rott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease
Jenny-Ann Phan et al.
SCIENTIFIC REPORTS (2017)
O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson's disease
Willayat Y. Wani et al.
MOLECULAR BRAIN (2017)
Alzheimer's Disease and the Amyloid-β Peptide
M. Paul Murphy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease
Hugo Vicente Miranda et al.
SCIENTIFIC REPORTS (2017)
Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations
Shruti Sahay et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2017)
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
Hugo Vicente Miranda et al.
BRAIN (2017)
Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization
Filsy Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes
Saida Abounit et al.
EMBO JOURNAL (2016)
Alzheimer's and Parkinson's Diseases: Expected Economic Impact on Europe-A Call for a Uniform European Strategy
Petra Maresova et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
SUMO-regulated mitochondrial function in Parkinson's disease
Ana Cristina Guerra de Souza et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease
Nour K. Majbour et al.
MOLECULAR NEURODEGENERATION (2016)
Motor symptoms in Parkinson's disease: A unified framework
Ahmed A. Moustafa et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patients
Wenyan Kang et al.
SCIENTIFIC REPORTS (2016)
Phosphorylation induces distinct alpha-synuclein strain formation
Meng-Rong Ma et al.
SCIENTIFIC REPORTS (2016)
Parkinson Disease Mutant E46K Enhances α-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, and in Vivo
Martial Kamdem Mbefo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Progressive Aggregation of Alpha-Synuclein and Selective Degeneration of Lewy Inclusion-Bearing Neurons in a Mouse Model of Parkinsonism
Valerie R. Osterberg et al.
CELL REPORTS (2015)
The H50Q Mutation Induces a 10-fold Decrease in the Solubility of α-Synuclein
Riccardo Porcari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells
Mohamed-Bilal Fares et al.
HUMAN MOLECULAR GENETICS (2014)
Structural Characterization of Heparin-induced Glyceraldehyde-3-phosphate Dehydrogenase Protofibrils Preventing α- Synuclein Oligomeric Species Toxicity
Cesar L. Avila et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction
Eric S. Luth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Function and Regulation of the Na + -Ca2+ Exchanger NCX3 Splice Variants in Brain and Skeletal Muscle
Lauriane Y. M. Michel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Evidence of Native α-Synuclein Conformers in the Human Brain
Neal Gould et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The H50Q Mutation Enhances α-Synuclein Aggregation, Secretion, and Toxicity
Ossama Khalaf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Divergent effects of the H5OQ and G51D SNCA mutations on the aggregation of α-synuclein
Nicola J. Rutherford et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells
Rita Perfeito et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2014)
IN VIVO MODULATION OF POLO-LIKE KINASES SUPPORTS A KEY ROLE FOR PLK2 IN SER129 α-SYNUCLEIN PHOSPHORYLATION IN MOUSE BRAIN
M. Bergeron et al.
NEUROSCIENCE (2014)
Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour
Giuliana Fusco et al.
NATURE COMMUNICATIONS (2014)
Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death
Mathieu Bourdenx et al.
FRONTIERS IN NEUROANATOMY (2014)
A 6.4 Mb Duplication of the α-Synuclein Locus Causing Frontotemporal Dementia and Parkinsonism Phenotype-Genotype Correlations
Eleanna Kara et al.
JAMA NEUROLOGY (2014)
Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
Lorraine V. Kalia et al.
MOVEMENT DISORDERS (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking
Bong-Kyu Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Suppression of -synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context
Vicente Sancenon et al.
HUMAN MOLECULAR GENETICS (2012)
Mutant Protein A30P α-Synuclein Adopts Wild-type Fibril Structure, Despite Slower Fibrillation Kinetics
Luisel R. Lemkau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Endoplasmic Reticulum Stress Is Important for the Manifestations of α-Synucleinopathy In Vivo
Emanuela Colla et al.
JOURNAL OF NEUROSCIENCE (2012)
Protein Electrostatic Properties Predefining the Level of Surface Hydrophobicity Change upon Phosphorylation
Anton A. Polyansky et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2012)
Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
P. G. Foulds et al.
NEUROBIOLOGY OF DISEASE (2012)
Differential Activation of the ER Stress Factor XBP1 by Oligomeric Assemblies
Diana L. Castillo-Carranza et al.
NEUROCHEMICAL RESEARCH (2012)
Human Polycomb protein 2 promotes α-synuclein aggregate formation through covalent SUMOylation
Yohan Oh et al.
BRAIN RESEARCH (2011)
Sumoylation inhibits α-synuclein aggregation and toxicity
Petranka Krumova et al.
JOURNAL OF CELL BIOLOGY (2011)
N-terminal deletion does not affect α-synuclein membrane binding, self-association and toxicity in human neuroblastoma cells, unlike yeast
Katherina Vamvaca et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Enhanced Phosphatase Activity Attenuates α-Synucleinopathy in a Mouse Model
Kang-Woo Lee et al.
JOURNAL OF NEUROSCIENCE (2011)
SNCA Triplication Parkinson's Patient's iPSC-derived DA Neurons Accumulate α-Synuclein and Are Susceptible to Oxidative Stress
Blake Byers et al.
PLOS ONE (2011)
Ubiquitin ligase Nedd4 promotes α-synuclein degradation by the endosomal-lysosomal pathway
George K. Tofaris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Peter Walter et al.
SCIENCE (2011)
Membrane Curvature Induction and Tubulation Are Common Features of Synucleins and Apolipoproteins
Jobin Varkey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target
Christopher G. Evans et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
ER stress response plays an important role in aggregation of α-synuclein
Peizhou Jiang et al.
MOLECULAR NEURODEGENERATION (2010)
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
Hong Qing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate
Isao Fukuda et al.
CHEMISTRY & BIOLOGY (2009)
Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System
Kelly J. Inglis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The First N-terminal Amino Acids of α-Synuclein Are Essential for α-Helical Structure Formation In Vitro and Membrane Binding in Yeast
Katherina Vamvaca et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Neuropsychiatric Symptoms in Parkinson's Disease
Dag Aarsland et al.
MOVEMENT DISORDERS (2009)
NUCLEAR AND NEURITIC DISTRIBUTION OF SERINE-129 PHOSPHORYLATED α-SYNUCLEIN IN TRANSGENIC MICE
H. Schell et al.
NEUROSCIENCE (2009)
Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease
Simone Engelender
AUTOPHAGY (2008)
Autophagy in the pathogenesis of disease
Beth Levine et al.
CELL (2008)
Non-motor symptoms in Parkinson's disease
W. Poewe
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Monoubiquitylation of α-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells
Ruth Rott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human α-synuclein:: Implication for α-synucleinopathies
Aasami Ishii et al.
FEBS LETTERS (2007)
The impact of the E46K mutation on the properties of α-synuclein in its monomeric and oligomeric states
Ross A. Fredenburg et al.
BIOCHEMISTRY (2007)
Extensive nuclear localization of α-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody
S. Yu et al.
NEUROSCIENCE (2007)
Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease
T. Franck et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Eirene Kontopoulos et al.
HUMAN MOLECULAR GENETICS (2006)
α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
Antony A. Cooper et al.
SCIENCE (2006)
DNA damage-induced cell death by apoptosis
Wynand P. Roos et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents
K Morino et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy
DL Pountney et al.
NEUROSCIENCE LETTERS (2005)
Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations
MM Dedmon et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Protein posttranslational modifications: The chemistry of proteome diversifications
CT Walsh et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Ubiquitylation of synphilin-1 and α-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease
E Liani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The novel functions of ubiquitination in signaling
LJ Sun et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
DJ-1 has a role in antioxidative stress to prevent cell death
T Taira et al.
EMBO REPORTS (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
DW Miller et al.
NEUROLOGY (2004)
Nuclear localization of α-synuclein and its interaction with histones
J Goers et al.
BIOCHEMISTRY (2003)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Structural and functional implications of C-terminal regions of α-synuclein
TD Kim et al.
BIOCHEMISTRY (2002)
Conformational behavior of human α-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T
J Li et al.
NEUROTOXICOLOGY (2002)
Nonmotor fluctuations in Parkinson's disease -: Frequent and disabling
T Witjas et al.
NEUROLOGY (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human α-synuclein
J Li et al.
BIOCHEMISTRY (2001)
Sumo, ubiquitin's mysterious cousin
S Müller et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Synucleins are a novel class of substrates for G protein-coupled receptor kinases
AN Pronin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)